Alliance Therapeutics

Alliance Therapeutics is the parent company of

Arizona Cancer Therapeutics

We are currently in the process of developing a drug (we call EJ1) this drug has strong data indicating that it may be effective therapy for breast, lung and brain cancer.  We are in the phase of producing a large batch of EJ1 for the IND-enabling toxicology studies Compound formulation (including scale-up for human use) & IND-enabling toxicology studies.  This Compound was granted a U.S. Patent  in October 2016.